Abstract
This chapter intends to introduce the reader to current approaches to targeted treatment for type 1 diabetes (T1D) with the current gold standard clinical therapies that are now offered. In particular, it reviews the most successful transplant techniques for patients with type 1 diabetes and secondary complications. It also provides an in-depth insight into the new frontiers in β-islet cell replacement showing the newest and most novel ways in which scientists and clinicians are now targeting the development of insulin-producing cells in the laboratory, which remains a major focus to finding a cure for type 1 diabetes. This chapter focuses specifically on the newest genetic engineering methods to prevent the onset of diabetes at various stages by a number of techniques to provide numerous ways to produce surrogate β-cells to replace a patient’s own destroyed islet cells. These technologies discussed also include genetic manipulation of the patient’s own cells to produce insulin or ways and techniques to substitute them with the latest types of β-islet cell replacement. These arise in the form of xeno-islet cell transplants and the novel ways by which to prevent their rejection. This ultimately has the ability to achieve the Holy Grail of permanently curing a patient of their type 1 diabetes .
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akima S et al (2006) Differences in the responses to recombinant human activated protein C against allogeneic and xenogeneic IBMIR. Transplantation 82(1):992
Akima S et al (2009) Tirofiban and activated protein C synergistically inhibit the instant blood mediated inflammatory reaction (IBMIR) from allogeneic islet cells exposure to human blood. Am J Transplant 9(7):1533–1540
Allen RD et al (1997) Diabetic neuropathy after pancreas transplantation: determinants of recovery. Transplantation 63(6):830–838
Allen RD et al (2001) Pancreas and islet transplantation: an unfinished journey. Transplant Proc 33(7–8):3485–3488
Anazawa T et al (2010) Improved method of porcine pancreas procurement with arterial flush and ductal injection enhances islet isolation outcome. Transplant Proc 42(6):2032–2035
Ansari MJ et al (2003) The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 198(1):63–69
Babizhayev MA et al (2013) Diabetes mellitus: novel insights, analysis and interpretation of pathophysiology and complications management with imidazole-containing peptidomimetic antioxidants. Recent Pat Drug Deliv Formul 7(3):216–256
Balamurugan AN et al (2014) Islet product characteristics and factors related to successful human islet transplantation from the Collaborative Islet Transplant Registry (CITR) 1999–2010. Am J Transplant 14(11):2595–2606
Banting FG et al (1922) Pancreatic extracts in the treatment of diabetes mellitus. Can Med Assoc J 12(3):141–146
Barbu AR et al (2006) A perfusion protocol for highly efficient transduction of intact pancreatic islets of Langerhans. Diabetologia 49(10):2388–2391
Becker TC et al (1994) Overexpression of hexokinase I in isolated islets of Langerhans via recombinant adenovirus. Enhancement of glucose metabolism and insulin secretion at basal but not stimulatory glucose levels. J Biol Chem 269(33):21234–21238
Bennet W et al (2000a) Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation 69(5):711–719
Bennet W et al (2000b) Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups J Med Sci 105(2):125–133
Bergenstal RM et al (2010) Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 363(4):311–320
Bobisse S, Zanovello P, Rosato A (2007) T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy. Expert Opin Biol Ther 7(6):893–906
Boitard C (2012) Pancreatic islet autoimmunity. Presse Med 41(12 p 2):e636–e650
Brady JL et al (2013) Anti-CD2 producing pig xenografts effect localized depletion of human T cells in a huSCID model. Xenotransplantation 20(2):100–109
Bregenholt S et al (2003) The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes. Scand J Immunol 57(5):432–438
Bruni A et al (2014) Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges. Diabetes Metab Syndr Obes 7:211–223
Callewaert H et al (2007) Cell loss during pseudoislet formation hampers profound improvements in islet lentiviral transduction efficacy for transplantation purposes. Cell Transplant 16(5):527–537
Cardona K et al (2006) Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 12(3):304–306
Carrington EM et al (2010) BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs. Proc Natl Acad Sci USA 107(24):10967–10971
Chow VC et al (1999) Diabetic retinopathy after combined kidney-pancreas transplantation. Clin Transplant 13(4):356–362
Cole CN, Crawford LV, Berg P (1979) Simian virus 40 mutants with deletions at the 3’ end of the early region are defective in adenovirus helper function. J Virol 30(3):683–691
Contreras JL et al (2002) Cytoprotection of pancreatic islets before and early after transplantation using gene therapy. Kidney Int 61(1 Suppl):S79–S84
Cooper DK et al (2014) Progress in pig-to-non-human primate transplantation models (1998-2013): a comprehensive review of the literature. Xenotransplantation 21(5):397–419
Couri CE et al (2009) C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 301(15):1573–1579
Cowan PJ, Cooper DK, d’Apice AJ (2014) Kidney xenotransplantation. Kidney Int 85(2):265–275
Coyle ME, Francis K, Chapman Y (2013) Self-management activities in diabetes care: a systematic review. Aust Health Rev 37(4):513–522
Creusot RJ et al (2008) Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice. Clin Immunol 127(2):176–187
Csete ME et al (1995) Efficient gene transfer to pancreatic islets mediated by adenoviral vectors. Transplantation 59(2):263–268
Cullen KS et al (2014) Glucagon induces translocation of glucokinase from the cytoplasm to the nucleus of hepatocytes by transfer between 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase-2 and the glucokinase regulatory protein. Biochim Biophys Acta 1843(6):1123–1134
Denes B et al (2006) Suppression of hyperglycemia in NOD mice after inoculation with recombinant vaccinia viruses. Mol Biotechnol 34(3):317–327
Dirice E et al (2009) Adenovirus-mediated TRAIL gene (Ad5hTRAIL) delivery into pancreatic islets prolongs normoglycemia in streptozotocin-induced diabetic rats. Hum Gene Ther 20(10):1177–1189
du Toit DF et al (1998) Immunosuppression with cyclosporin A in combination with mycophenolate mofetil suppresses rejection of allogeneic fetal rat pancreatic allografts. Transplant Proc 30(8):4092–4093
Dupraz P et al (1999) Lentivirus-mediated Bcl-2 expression in betaTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion. Gene Ther 6(6):1160–1169
Falorni A et al (1996) Culture maintenance of isolated adult porcine pancreatic islets in three-dimensional gel matrices: morphologic and functional results. Pancreas 12(3):221–229
Feng X et al (2000) Inducible nitric oxide synthetase is expressed in adult but not fetal pig pancreatic islets. Xenotransplantation 7(3):197–205
Fernandes JR et al (2004) Transplantation of islets transduced with CTLA4-Ig and TGFbeta using adenovirus and lentivirus vectors. Transpl Immunol 13(3):191–200
Fodor A et al (2007) Adult rat liver cells transdifferentiated with lentiviral IPF1 vectors reverse diabetes in mice: an ex vivo gene therapy approach. Diabetologia 50(1):121–130
Franceschi RT, Ge C (2008) Gene delivery by adenoviruses. Methods Mol Biol 455:137–147
Georgiou HM et al (1997) Genetic modification of an islet tumor cell line inhibits its rejection. Transplant Proc 29(1–2):1032–1033
Gerace D et al (2013) Pancreatic transdifferentiation in porcine liver following lentiviral delivery of human furin-cleavable insulin. Transplant Proc 45(5):1869–1874
Giannoukakis N et al (2000) Prevention of beta cell dysfunction and apoptosis activation in human islets by adenoviral gene transfer of the insulin-like growth factor I. Gene Ther 7(23):2015–2022
Ginn SL et al (2004) 405. Efficient lentivirus vector-mediated transduction of neonatal porcine islet cell clusters: a powerful tool for xenotransplantation research. Mol Ther 9(S1):S155–S156
Glaser B (2007) Type 2 diabetes: hypoinsulinism, hyperinsulinism, or both? PLoS Med 4(4):e148
Golden B et al (2005) Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J Clin Endocrinol Metab 90(8):4904–4911
Grey ST et al (1999) A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets. J Exp Med 190(8):1135–1146
Grinberg-Bleyer Y et al (2010) IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J Exp Med 207(9):1871–1878
Groth CG et al (1998) Pig-to-human islet transplantation. Transplant Proc 30(7):3809–3810
Gubitosi-Klug RA (2014) The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: summary and future directions. Diabetes Care 37(1):44–49
Halban PA et al (2001) Gene and cell-replacement therapy in the treatment of type 1 diabetes: how high must the standards be set? Diabetes 50(10):2181–2191
Hamaguchi K, Gaskins HR, Leiter EH (1991) NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes 40(7):842–849
Hawthorne WJ (2014) STATE OF THE ART 4: Janssen-Cilag symposium: islet xenotransplantation—update. Immunol Cell Biol 92:A1–A29
Hawthorne WJ et al (2000) A large-animal model to evaluate the clinical potential of fetal pig pancreas fragment transplantation. Cell Transplant 9(6):867–875
Hawthorne WJ et al (2011) Pre-clinical model of composite foetal pig pancreas fragment/renal xenotransplantation to treat renal failure and diabetes. Xenotransplantation 18(6):390–399
Hawthorne W et al (2014) Survival of genetically modified porcine neonatal islet xenografts in baboons. Transplantation 98:414
He Z et al (2006) Long-term gene expression and metabolic control exerted by lentivirus-transduced pancreatic islets. Xenotransplantation 13(3):195–203
Hering BJ et al (2006) Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 12(3):301–303
Holm P et al (2004) Interaction and association analysis of a type 1 diabetes susceptibility locus on chromosome 5q11-q13 and the 7q32 chromosomal region in Scandinavian families. Diabetes 53(6):1584–1591
Hsu PY, Kotin RM, Yang YW (2008) Glucose- and metabolically regulated hepatic insulin gene therapy for diabetes. Pharm Res 25(6):1460–1468
Hu ZQ et al (1994) Mast cells display natural suppressor activity partially by releasing transforming growth factor-beta. Immunology 82(3):482–486
Jacobs-Tulleneers-Thevissen D et al (2013) Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient. Diabetologia 56(7):1605–1614
Jimenez-Vera E, Davies S, Phillips P, O’Connell PJ, Hawthorne WJ (2015) Long-term cultured neonatal islet cell clusters demonstrate better outcomes for reversal of diabetes: in-vivo and molecular profiles. Xenotransplantation 22:114–123
Johnson MC et al (2013) beta-cell-specific IL-2 therapy increases islet Foxp3 + Treg and suppresses type 1 diabetes in NOD mice. Diabetes 62(11):3775–3784
Karamitsos DT (2011) The story of insulin discovery. Diabetes Res Clin Pract 93(Suppl 1):S2–S8
Katagi M et al (2014) Hyperglycemia induces abnormal gene expression in hematopoietic stem cells and their progeny in diabetic neuropathy. FEBS Lett 588(6):1080–1086
Kawabata K, Tashiro K, Mizuguchi H (2010) Differentiation of functional cells from iPS cells by efficient gene transfer. Yakugaku Zasshi 130(11):1527–1534
Kawamoto K et al (2008) Prolonged survival of pig islets xenograft by adenovirus-mediated expression of either the membrane-bound human FasL or the human decoy Fas antigen gene. Xenotransplantation 15(5):333–343
Kin T et al (2005) Reversal of diabetes in pancreatectomized pigs after transplantation of neonatal porcine islets. Diabetes 54(4):1032–1039
Klein D et al (2000) Inhibition of Fas-mediated apoptosis in mouse insulinoma betaTC-3 cells via an anti-Fas ribozyme. Hum Gene Ther 11(7):1033–1045
Kodama K et al (2008) Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice. Clin Immunol 129(2):195–201
Koizumi M et al (2006) Forced expression of PDX-1 induces insulin production in intestinal epithelia. Surgery 140(2):273–280
Kojima S et al (2009) Central leptin gene therapy, a substitute for insulin therapy to ameliorate hyperglycemia and hyperphagia, and promote survival in insulin-deficient diabetic mice. Peptides 30(5):962–966
Korbutt GS et al (1996) Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest 97(9):2119–2129
Korsgren O et al (1991) Functional and morphological differentiation of fetal porcine islet-like cell clusters after transplantation into nude mice. Diabetologia 34(6):379–386
Lam VW et al (2010) Evolution of pancreas transplant surgery. ANZ J Surg 80(6):411–418
Lee KM et al (2014) TGF-beta-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance. Eur J Immunol 44(6):1728–1736
Lei P et al (2007) Efficient production of bioactive insulin from human epidermal keratinocytes and tissue-engineered skin substitutes: implications for treatment of diabetes. Tissue Eng 13(8):2119–2131
Leibowitz G et al (1999) Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes 48(4):745–753
Levine F (1997) Gene therapy for diabetes: strategies for beta-cell modification and replacement. Diabetes Metab Rev 13(4):209–246
Liu YP, Berkhout B (2014) HIV-1-based lentiviral vectors. Methods Mol Biol 1087:273–284
Loganathan G et al (2014) Pretreatment of donor pigs with a diet rich in soybean oil increases the yield of isolated islets. Transplant Proc 46(6):1945–1949
Lu Y (2004) Recombinant adeno-associated virus as delivery vector for gene therapy–a review. Stem Cells Dev 13(1):133–145
MacKenzie DA, Hullett DA, Sollinger HW (2003) Xenogeneic transplantation of porcine islets: an overview. Transplantation 76(6):887–891
Mandel TE, Koulmanda M (1995) Xenotransplantation of fetal pig pancreas and reversal of diabetes in spontaneously diabetic NOD mice. Transplant Proc 27(3):2179–2180
Manolios N et al (1997) T-cell antigen receptor transmembrane peptides modulate T-cell function and T cell-mediated disease. Nat Med 3(1):84–88
McCulloch D (2007) Classification of diabetes mellitus and genetic diabetic syndromes. In: Rose B (ed) UpToDate. UpToDate: Waltham, MA
Meagher C et al (2007) CCL4 protects from type 1 diabetes by altering islet beta-cell-targeted inflammatory responses. Diabetes 56(3):809–817
Mia S et al (2014) An optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGF-beta yields a dominant immunosuppressive phenotype. Scand J Immunol 79(5):305–314
Mitanchez D et al (1997) Glucose-stimulated genes and prospects of gene therapy for type I diabetes. Endocr Rev 18(4):520–540
Miyagawa S et al (2010) Complement regulation in the GalT KO era. Xenotransplantation 17(1):11–25
Miyazaki J et al (1990) Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127(1):126–132
Moberg L et al (2002) Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 360(9350):2039–2045
Moore HP et al (1983) Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proteolytic processing, and secretion on stimulation. Cell 35(2 Pt 1):531–538
Morrissey PE, Monaco AP (2014) Donation after circulatory death: current practices, ongoing challenges, and potential improvements. Transplantation 97(3):258–264
Naldini L (2011) Ex vivo gene transfer and correction for cell-based therapies. Nat Rev Genet 12(5):301–315
Nankivell BJ et al (1997) Recovery of diabetic neuropathy after pancreas transplantation. Transplant Proc 29(1–2):658–659
Nayerossadat N, Maedeh T, Ali PA (2012) Viral and nonviral delivery systems for gene delivery. Adv Biomed Res 1:27
Niu L et al (2008) Gene therapy for type 1 diabetes mellitus in rats by gastrointestinal administration of chitosan nanoparticles containing human insulin gene. World J Gastroenterol 14(26):4209–4215
Nottle MB et al (2007) Production of homozygous alpha-1,3-galactosyltransferase knockout pigs by breeding and somatic cell nuclear transfer. Xenotransplantation 14(4):339–344
O’Connell PJ et al (2006) Clinical islet transplantation in type 1 diabetes mellitus: results of Australia’s first trial. Med J Aust 184(5):221–225
O’Connell PJ et al (2013) Transplantation of xenogeneic islets: are we there yet? Curr Diab Rep 13(5):687–694
Olson DE et al (2008) Hepatic insulin gene therapy normalizes diurnal fluctuation of oxidative metabolism in diabetic BB/Wor rats. Mol Ther 16(7):1235–1242
Ozmen L et al (2002) Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes 51(6):1779–1784
Panakanti R, Mahato RI (2009) Bipartite adenoviral vector encoding hHGF and hIL-1Ra for improved human islet transplantation. Pharm Res 26(3):587–596
Plesner A et al (2010) XIAP inhibition of beta-cell apoptosis reduces the number of islets required to restore euglycemia in a syngeneic islet transplantation model. Islets 2(1):18–23
Prud’homme GJ, Draghia-Akli R, Wang Q (2007) Plasmid-based gene therapy of diabetes mellitus. Gene Ther 14(7):553–564
Rabinovitch A et al (1999) Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes 48(6):1223–1229
Rafeullah N, Cackett N, Hussain K (2012) Fasting hypoglycaemia and postprandial hyperglycaemia as a prodrome of type 1 diabetes mellitus. Horm Res Paediatr 78(5–6):332–335
Rahmati S, Alijani N, Kadivar M (2013) In vitro generation of glucose-responsive insulin producing cells using lentiviral based pdx-1 gene transduction of mouse (C57BL/6) mesenchymal stem cells. Biochem Biophys Res Commun 437(3):413–419
Ravassard P et al (2011) A genetically engineered human pancreatic beta cell line exhibiting glucose-inducible insulin secretion. J Clin Invest 121(9):3589–3597
Ren B et al (2007) Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy. Diabetologia 50(9):1910–1920
Ren B et al (2013) Long-term reversal of diabetes in non-obese diabetic mice by liver-directed gene therapy. J Gene Med 15(1):28–41
Rood PP et al (2005) Preformed antibodies to alpha1,3-galactosyltransferase gene-knockout (GT-KO) pig cells in humans, baboons, and monkeys: implications for xenotransplantation. Transplant Proc 37(8):3514–3515
Sachs DH, Galli C (2009) Genetic manipulation in pigs. Curr Opin Organ Transplant 14(2):148–153
Sadeghi H et al (2002) Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo. Immunology 106(2):237–245
Scalea J et al (2012) T-cell-mediated immunological barriers to xenotransplantation. Xenotransplantation 19(1):23–30
Schambach A et al (2013) Biosafety features of lentiviral vectors. Hum Gene Ther 24(2):132–142
Scharfmann R et al (2014) Development of a conditionally immortalized human pancreatic beta cell line. J Clin Invest 124(5):2087–2098
Selden RF et al (1987) Regulation of insulin-gene expression. Implications for gene therapy. N Engl J Med 317(17):1067–1076
Shahrestani S WA, Lam VW, Yuen L, Ryan B, Pleass HC, Hawthorne WJ (2016) Outcomes from pancreatic transplantation in donation after cardiac death: a systematic review and meta-analysis. Transplantation 2016, Mar 4. [Epub ahead of print] PMID: 26950713
Shapiro AM et al (2006) International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355(13):1318–1330
Shternhall-Ron K et al (2007) Ectopic PDX-1 expression in liver ameliorates type 1 diabetes. J Autoimmun 28(2–3):134–142
Sigalla J et al (1997) Adenovirus-mediated gene transfer into isolated mouse adult pancreatic islets: normal beta-cell function despite induction of an anti-adenovirus immune response. Hum Gene Ther 8(13):1625–1634
Sobel DO, Henzke A, Abbassi V (2010) Cyclosporin and methotrexate therapy induces remission in type 1 diabetes mellitus. Acta Diabetol 47(3):243–250
Soltani N et al (2007) In vivo expression of GLP-1/IgG-Fc fusion protein enhances beta-cell mass and protects against streptozotocin-induced diabetes. Gene Ther 14(12):981–988
Sun JB, Holmgren J, Czerkinsky C (1994) Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci USA 91(23):10795–10799
Sutherland RM et al (2000) Protective effect of CTLA4Ig secreted by transgenic fetal pancreas allografts. Transplantation 69(9):1806–1812
Talebi S et al (2012) Derivation of islet-like cells from mesenchymal stem cells using PDX1-transducing lentiviruses. Biotechnol Appl Biochem 59(3):205–212
Tang DQ et al (2013) Genetically reprogrammed, liver-derived insulin-producing cells are glucose-responsive, but susceptible to autoimmune destruction in settings of murine model of type 1 diabetes. Am J Transl Res 5(2):184–199
Thompson DM et al (2011a) Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation 91(3):373–378
Thompson P et al (2011b) Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function. Am J Transplant 11(12):2593–2602
Thompson P et al (2012) Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survival. Am J Transplant 12(7):1765–1775
Thwaites SE et al (2012) Excellent outcomes of simultaneous pancreas kidney transplantation in patients from rural and urban Australia: a national service experience. Transplantation 94(12):1230–1235
Tian C et al (2007) Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy. J Immunol 179(10):6762–6769
Tian J et al (2008) Regulated insulin delivery from human epidermal cells reverses hyperglycemia. Mol Ther 16(6):1146–1153
Tiwari JL et al (2012) Islet cell transplantation in type 1 diabetes: an analysis of efficacy outcomes and considerations for trial designs. Am J Transplant 12(7):1898–1907
Torchilin VP (2006) Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annu Rev Biomed Eng 8:343–375
Toso C et al (2000) Isolation of adult porcine islets of Langerhans. Cell Transplant 9(3):297–305
Tuduri E, Bruin JE, Kieffer TJ (2012) Restoring insulin production for type 1 diabetes. J Diabetes 4(4):319–331
Vågesjö E, Christoffersson G, Waldén TB, Carlsson PO, Essand M, Korsgren O, Phillipson M (2015) Immunological shielding by induced recruitment of regulatory T-lymphocytes delays rejection of islets transplanted to muscle. Cell Transplant 24(2):263–276
van der Windt DJ et al (2009) Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant 9(12):2716–2726
Vizzardelli C et al (2002) Neonatal porcine pancreatic cell clusters as a potential source for transplantation in humans: characterization of proliferation, apoptosis, xenoantigen expression and gene delivery with recombinant AAV. Xenotransplantation 9(1):14–24
Voltarelli JC et al (2007) Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 297(14):1568–1576
Waldron-Lynch F, Herold KC (2011) Immunomodulatory therapy to preserve pancreatic beta-cell function in type 1 diabetes. Nat Rev Drug Discov 10(6):439–452
Wirth T, Parker N, Yla-Herttuala S (2013) History of gene therapy. Gene 525(2):162–169
Xia J et al (2011) Evaluation of biolistic gene transfer methods in vivo using non-invasive bioluminescent imaging techniques. BMC Biotechnol 11:62
Xu J et al (2007) Reversal of diabetes in mice by intrahepatic injection of bone-derived GFP-murine mesenchymal stem cells infected with the recombinant retrovirus-carrying human insulin gene. World J Surg 31(9):1872–1882
Xu AJ et al (2010) Effects of adenovirus-mediated interleukin-10 gene transfer on apoptosis and insulin secretion function of beta cell. Zhonghua Yi Xue Za Zhi 90(24):1711–1715
Yi S et al (2003) T cell-activated macrophages are capable of both recognition and rejection of pancreatic islet xenografts. J Immunol 170(5):2750–2758
Yi S et al (2005) Involvement of CCR5 signaling in macrophage recruitment to porcine islet xenografts. Transplantation 80(10):1468–1475
Yi S et al (2012) Adoptive transfer with in vitro expanded human regulatory T cells protects against porcine islet xenograft rejection via interleukin-10 in humanized mice. Diabetes 61(5):1180–1191
Yoon KH et al (1999) Differentiation and expansion of beta cell mass in porcine neonatal pancreatic cell clusters transplanted into nude mice. Cell Transplant 8(6):673–689
Zhang Y et al (2008) Genetically engineered K cells provide sufficient insulin to correct hyperglycemia in a nude murine model. Acta Biochim Biophys Sin (Shanghai) 40(2):149–157
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hawthorne, W.J. (2016). Beta Cell Therapies for Type 1 Diabetes. In: A. Hardikar, A. (eds) Pancreatic Islet Biology. Stem Cell Biology and Regenerative Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-45307-1_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-45307-1_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-45305-7
Online ISBN: 978-3-319-45307-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)